Minister of Health’s Decision that JAMP is not a “Second Person” Was Reasonable

In its new drug submission for SIMLANDI, a biosimilar containing adalimumab, JAMP Pharma Corporation (“JAMP”) sought approval for three specific presentations: (i) 40 mg/0.4 mL pre-filled syringe; (ii) 40 mg/0.4 mL auto-injector pen; and (iii) 80 mg/0.8 mL pre-filled syringe.
Given that AbbVie did not market the equivalent presentations of HUMIRA (adalimumab) in Canada, in a comprehensive and detailed decision, the Minister of Health (the “Minister”) determined that JAMP was not a “second person” for purposes of subsection 5(1) of the Patented Medicines (Notice of Compliance) Regulations (the “PM(NOC) Regulations”) and was thus not required to address patents listed on the patent register by AbbVie before being issued a Notice of Compliance (“NOC”).
Subsequently, the Minister issued an NOC to JAMP for its three presentations of SIMLANDI.
In AbbVie Corporation et al. v. The Minister of Health and JAMP Pharma Corporation, 2022 FC 1209, Justice Fothergill of the Federal Court dismissed AbbVie’s applications to judicially review the Minister’s decisions, on the basis that the Minister’s decisions were reasonable.
Justice Fothergill observed that the “PM(NOC) Regulations are closely connected with the Minister’s functions, and the Minister has great expertise in their application and interpretation”.
In summary, Justice Fothergill determined that the “Minister’s interpretation of s 5(1) of the PM(NOC) Regulations as applying only to a version of a drug that has a specific drug identification number [DIN] and that is marketed in Canada was reasonable, particularly considering the statutory objective of providing a patent enforcement mechanism only in relation to products that are in fact available to Canadians”.
Authors
Expertise
Insights
-
Intellectual Property Litigation
Bitcoin Bluff: Australian Man who Claimed he Invented Bitcoin is Found in Contempt of Court
As reported by AP News, an Australian computer scientist who falsely claimed to be the founder of bitcoin has been found to be in contempt of London’s High Court and given a suspended sentence of… -
Intellectual Property Litigation
Paws for Thought: DOGKIND Trademark Application Refused
In a recent decision, the Trademarks Opposition Board (“TMOB”) refused a trademark application for DOGKIND, finding it was confusingly similar to the already registered trademark, PETKIND.Dogkind… -
Intellectual Property Litigation
Rolling in the Injunctions: Brazilian judge orders Adele song to be removed from streaming services
A Brazilian judge has reportedly ordered that Adele’s 2015 song, “Million Years Ago”, be pulled from streaming services worldwide, following allegations of plagiarism from Brazilian musician, Toninho… -
Litigation and Dispute Resolution
Changes to Trademark Proceedings Coming into Effect April 1, 2025
Amendments to the Trademarks Regulations will take effect on April 1, 2025. These changes are part of broader updates to the Trademarks Act, introduced through the Budget Implementation Act, 2018, No… -
Intellectual Property Litigation
Heineken Battles Over "La Tropical" Branding
Heineken’s Lagunitas Brewery has reportedly advanced its trademark and copyright claims over its "La Tropical" beer in a legal battle involving Cuban-origin brands. As reported by Bloomberg, the… -
Intellectual Property Litigation
Super Loss for Marvel and DC? "Super Hero" Trademark Enters the Public Domain
Marvel and DC have reportedly lost their long-held trademarks for “Super Hero”. For decades, the two comic giants jointly owned the trademark, with DC using it for its DC Super Hero Cafe and…